Business | NDTV Correspondent | Wednesday November 23, 2011
Lupin receives FDA approval for Lamotrigine tablets
Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc
(LPI) has received final approval from U.S. Food and Drug Administration
(USFDA) for its Abbreviated New Drug Application for its Lamotrigine
tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.
Lupi...
www.ndtv.com/business